E-LIB Suche - Ergebnisse für: Ju, Han Sae

1

Patient-derived organoids as a preclinical platform for pre..:

Cho, Young-Won ; Min, Dong-Wook ; Kim, Hwang-Phill...
Molecular Oncology, Vol.16 No.12, pp.2396-2412. , 2022

Link: https://hdl.handle.net/1..

2

Phase II Study of Avelumab in Patients with Advanced Hepato..:

Lee, Dae-Won ; Cho, Eun Ju ; Lee, Jeong-Hoon...
Clinical Cancer Research, Vol.27 No.3, pp.713-718. , 2021

Link: https://hdl.handle.net/1..

3

Antitumor activity of NVP-AUY922, a novel heat shock protei..:

Lee, Kyung-Hun ; Lee, Ju-Hee ; Han, Sae-Won...
Cancer Science, Vol.102 No.7, pp.1388-1395. , 2020

Link: https://hdl.handle.net/1..

4

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, ..:

Kim, Hwang-Phill ; Yoon, Young-Kwang ; Kim, Jin-Won...
PLoS ONE, Vol.4 No.6, p. e5933. , 2020

Link: https://hdl.handle.net/1..

5

TTP as a surrogate endpoint in advanced hepatocellular carc..:

Lee, Dae-Won ; Jang, Myoung-Jin ; Lee, Kyung-Hun...
British Journal of Cancer, Vol.115 No.10, pp.1201-1205. , 2018

Link: https://hdl.handle.net/1..

6

Predictive significance of p53, Ki-67, and Bcl-2 expression..:

Kim, Taeryung ; Han, Wonshik ; Kim, Min Kyoon...
Journal of Breast Cancer, Vol.18 No.1, pp.16-21. , 2018

Link: https://hdl.handle.net/1..

7

Therapeutic implication of HER2 in advanced biliary tract c..:

Nam, Ah-Rong ; Kim, Ji-Won ; Cha, Yongjun...
Oncotarget, Vol.7 No.36, pp.58007-58021. , 2018

Link: https://hdl.handle.net/1..

8

KRAS mutation is associated with worse prognosis in stage I..:

Lee, Dae-Won ; Kim, Kyung Ju ; Han, Sae-Won...
Annals of Surgical Oncology, Vol.22 No.1, pp.187-194. , 2018

Link: https://hdl.handle.net/1..

9

Prognostic implication of antitumor immunity measured by th..:

Ock, Chan-Young ; Nam, Ah-Rong ; Lee, Joongyub...
Gastric Cancer, Vol.20 No.2, pp.254-262. , 2018

Link: https://hdl.handle.net/1..

10

Nomogram for predicting breast conservation after neoadjuva..:

Kim, Min Kyoon ; Han, Wonshik ; Moon, Hyeong-Gon...
Cancer Research and Treatment, Vol.47 No.2, pp.197-207. , 2018

Link: https://hdl.handle.net/1..

11

The distinct signatures of VEGF and soluble VEGFR2 increase..:

Ock, Chan-Young ; Nam, Ah-Rong ; Bang, Ju-Hee...
American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388. , 2018

Link: https://hdl.handle.net/1..

12

Src as a Therapeutic Target in Biliary Tract Cancer:

Nam, Ah-Rong ; Kim, Ji-Won ; Park, Ji Eun...
Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524. , 2018

Link: https://hdl.handle.net/1..

13

Signature of cytokines and angiogenic factors (CAFs) define..:

Ock, Chan-Young ; Nam, Ah-Rong ; Bang, Ju-Hee...
Gastric Cancer, Vol.20 No.1, pp.164-174. , 2018

Link: https://hdl.handle.net/1..

14

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to..:

Ha, Hyerim ; Nam, Ah-Rong ; Bang, Ju-Hee...
Oncotarget, Vol.7 No.47, pp.76604-76612. , 2018

Link: https://hdl.handle.net/1..

15

Adverse prognostic impact of the CpG island methylator phen..:

Cha, Yongjun ; Kim, Kyung-Ju ; Han, Sae-Won...
British Journal of Cancer, Vol.115 No.2, pp.164-171. , 2018

Link: https://hdl.handle.net/1..